BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2913280)

  • 21. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies.
    Mastaï R; Laganière S; Wanless IR; Giroux L; Rocheleau B; Huet PM
    Hepatology; 1996 Oct; 24(4):865-70. PubMed ID: 8855189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alteration of hepatic acetylation in uraemia.
    Fine A; Sumner D
    Proc Eur Dial Transplant Assoc; 1975; 11():433-40. PubMed ID: 1197268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between the metabolism of procainamide and sulfamethazine.
    Giardina E-GV ; Stein RM; Bigger JT
    Circulation; 1977 Feb; 55(2):388-94. PubMed ID: 832354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster.
    Hein DW; Omichinski JG; Brewer JA; Weber WW
    J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of hypercapnia and (or) hypoxemia and metabolic acidosis on sulfamethazine kinetics in the conscious rabbit.
    Du Souich P; Courteau H
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1170-7. PubMed ID: 6498628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation, and function in a rabbit model with extensive hepatic fibrosis.
    Jiao LR; Seifalian AM; Habib N; Davidson BR
    Hepatology; 1999 Jul; 30(1):46-52. PubMed ID: 10385637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hydrocortisone on the expression of mitochondrial genes in the liver of normal and alloxan diabetic rats.
    Minchenko AG; Germanyuk YaL
    Endocrinol Exp; 1984 Mar; 18(1):3-18. PubMed ID: 6201346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of an asialoglycoprotein receptor-targeted magnetic resonance contrast agent to study changes in receptor biology during liver regeneration and endotoxemia in rats.
    Leveille-Webster CR; Rogers J; Arias IM
    Hepatology; 1996 Jun; 23(6):1631-41. PubMed ID: 8675187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid-induced hepatic necrosis and steatosis in rabbits: absence of effect of gender.
    Sarich TC; Adams SP; Zhou T; Wright JM
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1108-11. PubMed ID: 9365821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains.
    Hein DW; Smolen TN; Fox RR; Weber WW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):40-4. PubMed ID: 7120125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic enzyme activity is the major factor determining elimination rate of high-clearance drugs in cirrhosis.
    Callaghan R; Desmond PV; Paull P; Mashford ML
    Hepatology; 1993 Jul; 18(1):54-60. PubMed ID: 8325621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of procainamide N-acetylation in the rat in vivo and in the perfused rat liver preparation.
    Pang KS; Huang JC; Finkle C; Kong P; Cherry WF; Fayz S
    Drug Metab Dispos; 1984; 12(3):314-22. PubMed ID: 6203693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction between oral hydralazine and propranolol. I. Changes in absorption, presystemic clearance and splanchnic blood flow.
    Heinzow B; Corbett H; Constantinides S; Bourne R; McLean AJ
    J Pharmacol Exp Ther; 1984 May; 229(2):509-14. PubMed ID: 6716273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ecogenetic studies of drug acetylation in man and rats.
    Dubbels R; Khoory R; Schloot W
    Acta Anthropogenet; 1981; 5(2):111-8. PubMed ID: 7271997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.
    Chow FS; Piekoszewski W; Jusko WJ
    Drug Metab Dispos; 1997 May; 25(5):610-6. PubMed ID: 9152601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic vs. gastrointestinal presystemic extraction of oral midazolam and flurazepam.
    Ochs HR; Greenblatt DJ; Eichelkraut W; Bakker C; Göbel R; Hahn N
    J Pharmacol Exp Ther; 1987 Dec; 243(3):852-6. PubMed ID: 3694534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
    Imawaka H; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.
    Jiao LR; El-Desoky AA; Seifalian AM; Habib N; Davidson BR
    Br J Surg; 2000 May; 87(5):568-74. PubMed ID: 10792311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of sulfanilamide and related drugs in isolated rat and rabbit liver cells.
    Suolinna EM
    Drug Metab Dispos; 1980; 8(4):205-7. PubMed ID: 6105051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.